Biologics targeting IL-17 and IL-23 maintain stability in patients with psoriasis during COVID-19 infection: a case-control study

Impact of SARS‐CoV ‐2 infection in children with psoriasis: Results of a monocentric experience

(2023) Francesca Caroppo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months

(2023) Marianna Santopaolo et al.   eLife

Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients

(2023) Shukur Wasman Smail et al.   Frontiers in Immunology

COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study

(2023) Georg Christian Lodde et al.   Frontiers in Immunology

The plasma metabolome of long COVID patients two years after infection

(2023) Yamilé López-Hernández et al.   Scientific Reports

Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19

(2023) Diana Martonik et al.   Frontiers in Immunology

Epigenetic Mechanisms of Epidermal Differentiation

(2022) Chiara Moltrasio et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 – Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

(2021) J.M. Gelfand et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

(2021) Kamran Ghoreschi et al.   LANCET

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review

(2021) Akshitha Thatiparthi et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Psoriasis

(2021) Christopher E M Griffiths et al.   LANCET

COVID ‐19 and exacerbation of dermatological diseases: A review of the available literature

(2021) Khashayar Aram et al.   Dermatologic Therapy

Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real‐life clinical practice) study

(2021) Delia Colombo et al.   Dermatologic Therapy

Psoriasis and COVID ‐19: A narrative review with treatment considerations

(2020) Ömer Faruk Elmas et al.   Dermatologic Therapy

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19

(2020) Qiannan Xu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Risk Factors for the Development of Psoriasis

(2019) Koji Kamiya et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES